Additionally, many manufacturers provide regulatory support, helping brands navigate the complex requirements for supplement marketing and distribution in various jurisdictions

Here's how they compare: Semaglutide (GLP-1 agonist) Mechanism: Single-action GLP-1 receptor agonist FDA status: Approved for type 2 diabetes and chronic weight management Expected weight loss: 15-20% of body weight in clinical trials Administration: Once-weekly injection Best for: Patients starting their weight loss journey seeking proven, well-studied medication Tirzepatide (dual GIP/GLP-1 agonist) Mechanism: Targets both GIP and GLP-1 receptors for enhanced metabolic effect FDA status: Approved for type 2 diabetes and chronic weight management Expected weight loss: Up to 22% of body weight in clinical trials Administration: Once-weekly injection Best for: Patients seeking more aggressive fat loss with dual-action metabolic support Retatrutide (triple agonist, not yet available) Mechanism: Targets GLP-1, GIP, and glucagon receptors FDA status: Not FDA-approved

Medications GLP-1s, oral weight loss medications Monthly Cost $149-$399 Speed to Start Moderate Trustpilot 4.4 / 5 (725+ reviews) Est
Anti-inflammatory Effects:BPC-157 helps to modulate the inflammatory response, which can reduce swelling and pain
hence, extreme dieting is not productive in the long run